The regulation and measurement of plasma volume in heart failure.
about
Measuring impedance in congestive heart failure: current options and clinical applicationsAnemia management in heart failure: a thick review of thin data.Fluid distribution kinetics during cardiopulmonary bypass.Treatment of anemia in heart failure: potential risks and benefits of intravenous iron therapy in cardiovascular disease.Cost-utility of ferric carboxymaltose (Ferinject®) for iron-deficiency anemia patients with chronic heart failure in South Korea.A comparison of continuous intravenous insulin and subcutaneous insulin among patients with type 2 diabetes and congestive heart failure exacerbation.Association of fluid retention with anemia and clinical outcomes among patients with chronic kidney disease.Advanced assessment of hemodynamic parameters during donor care.Measurement of plasma volume using fluorescent silica-based nanoparticles.Determinants of the accuracy of continuous glucose monitoring in non-critically ill patients with heart failure or severe hyperglycemia.Glycemic variability during algorithmic titration of insulin among hospitalized patients with type 2 diabetes and heart failureThe effect of congestive heart failure on sensor accuracy among hospitalized patients with type 2 diabetes.European Society of Cardiology-Acute Cardiovascular Care Association Position paper on acute heart failure: A call for interdisciplinary care.Promise of SGLT2 Inhibitors in Heart Failure: Diabetes and Beyond.Detection of preclinical body fluid retention in established heart failure patients during follow-up by a digital weight scale incorporating a bioelectrical impedance analyzer.Relationship between Plasma Albumin Concentration and Plasma Volume in 5 Inbred Rat Strains.Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure.Impact of diuretic treatment and sodium intake on plasma volume in patients with compensated systolic heart failure.Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials.Proposal for heart failure progression based on the 'chloride theory': worsening heart failure with increased vs. non-increased serum chloride concentration.Plasma Volume and Renal Function Predict Six-Month Survival after Hospitalization for Acute Decompensated Heart Failure.Calculated plasma volume status and prognosis in chronic heart failure.Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state.Arterial remodeling and plasma volume expansion in caveolin-1-deficient mice.CVP and PAoP measurements are discordant during fluid therapy after traumatic brain injury.Evaluation of Erythrocyte Changes After Normoxic Return from Hypoxia.Change in plasma volume and prognosis in acute decompensated heart failure: an observational cohort study.Cardiac output and systemic transit time dispersion as determinants of circulatory mixing time: a simulation study.Long-term survival of routine implantable cardioverter/defibrillator recipients appears to be significantly impaired with concomitant diuretics and improved with aldosterone antagonists.Blood volume measurement using cardiovascular magnetic resonance and ferumoxytol: preclinical validation
P2860
Q24596111-98A89F33-67B9-47F2-A1E4-30C433D28863Q30940154-3BF631AA-210E-452B-A080-5C91DD03B4A8Q34031354-15020713-DF55-42F9-BDE8-205E8294858BQ34064046-4551C719-8C5B-47D6-B684-794EB4A35FCEQ34200064-7DFE9339-83DD-411B-B15A-C7AABA660726Q34674958-636D1005-BAFB-4569-B588-8CB9C3750819Q35088155-490B7F7C-5895-4FE5-8048-86F8B3AD9CA3Q35650178-A9A76CD0-C7A6-4B2D-BE9C-CBC6131D3ABFQ35787478-7CC66864-E338-4B63-A45D-23D13AB9029FQ36229326-8A8A9558-FB1A-4880-9447-8E23A5C2F1C1Q36421410-9C964084-6167-4D37-9D19-52B9BD4D204DQ37192468-78B25AAE-E227-4A1B-B2E7-41AF37E2D4D8Q38540467-DC29D121-811A-48AB-A5EC-03B770237D62Q38744467-2C48E57E-3612-4CC5-88C0-D69AEAA1E63EQ40018056-1B552A4F-EFE3-4376-B57B-8AAC1BF04798Q40480386-F2004391-A176-4342-9038-E9647F023E2BQ42201388-2B563A74-A0B2-4ED3-88FE-81610943D689Q42975785-A9FBF6B9-C360-4F13-8D94-2FD568F89690Q44964814-18D01F68-CED8-4A12-B26A-A6C91C4C8FF2Q47445823-763FC7F1-6F20-46AB-B65E-827E75E7D33FQ47552094-C29D4980-E3F4-4AFB-9E19-27C40517B24AQ48425621-2E4AA04E-A2D1-40C7-91F9-3B7289E38125Q48475908-F0F4EA3F-840B-4B09-8921-E25D11ABA8EBQ48583829-4E400D1C-614E-4F18-B31E-377089C8FA5BQ49122604-934EFF28-994B-4C2C-9A87-02F07D38CCADQ50057447-AD475868-AE64-46F3-88E8-85FB53FA32BEQ50585584-32D0B19C-F711-487E-B08C-B61D55D1FF10Q50591949-C94F6A9F-0F30-4BAD-A8A0-DD6BFBD2431DQ52904775-8EDC1CC4-CC91-4F4C-8F68-B8BB29863D96Q58755175-C12FD57B-FA08-4BD9-B63C-D1C99269CB5B
P2860
The regulation and measurement of plasma volume in heart failure.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
The regulation and measurement of plasma volume in heart failure.
@ast
The regulation and measurement of plasma volume in heart failure.
@en
The regulation and measurement of plasma volume in heart failure.
@nl
type
label
The regulation and measurement of plasma volume in heart failure.
@ast
The regulation and measurement of plasma volume in heart failure.
@en
The regulation and measurement of plasma volume in heart failure.
@nl
prefLabel
The regulation and measurement of plasma volume in heart failure.
@ast
The regulation and measurement of plasma volume in heart failure.
@en
The regulation and measurement of plasma volume in heart failure.
@nl
P2093
P1476
The regulation and measurement of plasma volume in heart failure.
@en
P2093
Aidan P Bolger
Andrew J S Coats
Constantinos Anagnostopoulos
Paul R Kalra
P304
P356
10.1016/S0735-1097(02)01903-4
P407
P577
2002-06-01T00:00:00Z